Search
for
Sort by
Research 241–270 of 931
- Dermatological adverse events with taxane chemotherapy
- Frontal fibrosing alopecia: a survey in 16 patients
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Primary cicatricial alopecia
- Frontal fibrosing alopecia associated with cutaneous lichen planus in a premenopausal woman
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Alopecia Areata Update
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Management of Hair Loss
- Niosomes as a propitious carrier for topical drug delivery
- Nutrition and hair
- Folliculitis decalvans: a multicentre review of 82 patients
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Alopecia areata: An update
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- Interventions for nail psoriasis
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- The Role of Micronutrients in Alopecia Areata: A Review
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- The role of lymphocytes in the development and treatment of alopecia areata
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Diagnosis and Management of Alopecia in Children
- Advances in the management of alopecia areata
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis